TITLE:
Compliance with Oral Anti-Diabetic Treatment in Lome
AUTHORS:
Tchamdja Toyi, Djalogue Lihanimpo, Kodjo Kossi, Kaaga Laconi Yéba, Mossi Komi Edem, M’bortché B. Kodjo, Ehon Ata Edem, Djibril Mohaman Awalou, Balaka Abago
KEYWORDS:
Type II Diabetes, Metformin, Compliance, Associated Factors
JOURNAL NAME:
Open Journal of Internal Medicine,
Vol.14 No.1,
February
2,
2024
ABSTRACT: Objective: The objective of this study was to assess adherence to antidiabetic therapy in type II diabetic patients and factors associated with Lomé. Method: This was a descriptive observational study conducted among diabetics in diabetes care centers from May 1, 2020 to October 1, 2020, for a period of 6 months. Results: A total of 300 patients were questioned. The mean age was 56.61 years (standard deviation = 11.7). The sex ratio was 0.6. All the patients were on drug treatment, 83.4% of whom were on metformin and 37.5% on Glibenclamide. In 58.3% of the cases, the patients were on dual therapy and 96.2% had an abovenormal glycated hemoglobin value. There was a medication adherence problem with poor adherence in 30.7%. Being aged 50 and over (ORC = 1.78, p = 0.048), playing sports (ORR = 1.87, p = 0.046), have reaching a higher level of education (ORR = 5.78, p = 0.005) significantly increased the chances of patients having a good/minimal problem of adherence. Conclusion: Diabetes affects in Togo, more women than men with a predominance of those aged 50 and over. Adherence to therapy remains a challenge.